Chattanooga Times Free Press

Pancreatic Cancer Care and Understand­ing

- BY BRANDI DIXON

Pancreatic cancer is largely a silent disease process and an elusive type of cancer that affects 60,000 Americans each year. A person’s average lifetime risk of developing pancreatic cancer is about 1 in 65. Risks for developing the disease include smoking, obesity, and a family history of the disease or pancreatit­is.

While cancer tends to be more prevalent as we age, people in their 40s, 50s and 60s are more commonly diagnosed with pancreatic cancer. It’s most often found with computed tomography (CT) scans, endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI). Unfortunat­ely, these screening modalities are not 100 percent effective in finding small lesions, pre-cancer or early-stage cancers. For many people diagnosed – approximat­ely 30 percent – the cancer has already spread before symptoms become noticeable.

“The first signs of pancreatic cancer are typically abdominal or back pain that doesn’t go away, or the skin becomes jaundiced or yellow. Other symptoms include nausea, diarrhea, bloating and stool changes, along with loss of appetite, elevated blood sugar, weight loss and general fatigue,” says Alan Koffron, MD, pancreatic cancer specialist at University Surgical Associates. “Because pancreatic cancer is much easier to treat when it’s found early, it’s important to pay attention to your body’s signals and talk to your doctor if something’s not right.”

Why is pancreatic cancer difficult to treat?

Pancreatic cancer is a complicate­d condition to treat, specifical­ly because of the pancreas’ location deep within abdomen. Although it’s not a large organ, it’s nestled right next to the blood vessels that feed the other major organs and the lymph nodes that make insulin and digestive enzymes. Its location alone makes it a technicall­y difficult surgery to perform.

“The hope for any cancer – including pancreatic – is to surgically remove it using safe but aggressive techniques.

When the cancer is contained within the pancreas and hasn’t spread to surroundin­g tissue, surgery is the mainstay of treatment,” Dr. Koffron says. “For tumors that are larger and beginning to grow but haven’t spread to other organs, we often use neo-adjuvant chemothera­py, which means chemo that’s administer­ed before surgery. It’s used to shrink or slow the tumor’s growth so it becomes possible to remove. For individual­s whose disease has spread outside of the pancreas, chemothera­py and radiation are used to prolong survival.”

Why choose a Pancreatic Cancer Specialist?

Although we know pancreatic cancer treatment is complex, the diagnosis isn’t an automatic death sentence – particular­ly when you choose a surgeon with the experience and education needed to offer the very latest and most effective treatment options.

“It’s important for people to know that we have the most advanced cancer-fighting surgeries and treatments right here in Chattanoog­a. In the last 15 years or so, surgical fellowship­s that focus on the techniques and procedures of the liver and pancreas allow us to do very technicall­y difficult operations on a routine basis,” Dr. Koffron says. “The outcomes are better

when you seek care from a pancreatic cancer specialist at a high-volume center – meaning one that does more than 20 operations a year, which is what we do here at Erlanger. But more than that, you have access to a dedicated surgical and recovery care team and other cancer specialist­s who are all working together to fight your cancer and help you live a longer and healthier life.”

If you or a loved one has been diagnosed with pancreatic cancer, you have choices when it comes to your surgeon and your treatment options. For more informatio­n or to schedule an appointmen­t, call 423.267.0466.

 ?? ?? Dr. Alan Koffron is a fellowship trained multipleor­gan transplant and hepatobili­ary surgeon who specialize­s in liver and kidney transplant and advanced surgical treatment of conditions of the liver, pancreas and biliary system. He also serves as Surgical Director, Erlanger Kidney Transplant Center.
Dr. Alan Koffron is a fellowship trained multipleor­gan transplant and hepatobili­ary surgeon who specialize­s in liver and kidney transplant and advanced surgical treatment of conditions of the liver, pancreas and biliary system. He also serves as Surgical Director, Erlanger Kidney Transplant Center.
 ?? ?? Pancreatic cancer is a leading cause of cancer death – largely because early detection is difficult and symptoms are vague and often attributed to other health concerns. Studies show that not smoking, drinking in moderation, and maintainin­g a healthy body weight can reduce the risk of developing this deadly disease.
Pancreatic cancer is a leading cause of cancer death – largely because early detection is difficult and symptoms are vague and often attributed to other health concerns. Studies show that not smoking, drinking in moderation, and maintainin­g a healthy body weight can reduce the risk of developing this deadly disease.

Newspapers in English

Newspapers from United States